HealthcareNSE

Beta Drugs Limited

BETA · ISIN INE351Y01019

Share price

₹1,888▲ +2.86%

Market capitalisation

₹1906 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹1906 Cr

Current price

₹1,888

+2.86% today

52W high

₹2,000

52W low

₹990

Stock P/E

46.13

P/B ratio

7.82

02 · Per share & returns

EPS (TTM)

₹40.93

Book value

₹242

ROE

18.78%

ROA

7.85%

Dividend yield

0.00%

Beta

-0.46

03 · Financials (TTM)

By the numbers

Revenue

₹385 Cr

+0.20% YoY

EBITDA

₹75.68 Cr

Net profit

₹41.48 Cr

-5.00% YoY

Profit margin

10.78%

Operating margin

13.71%

Total debt

₹148 Cr

Total cash

₹125 Cr

Debt / equity

0.60x

Current ratio

3.10x

Payout ratio

0.00%

04 · Analyst view

Target price

—

Upside

—

Consensus

NONE

Analysts

—

05 · Shareholding pattern

Who owns BETA?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol: BETA
Exchange: NSE
CIN: —
ISIN: INE351Y01019
BSE code: —
Sector: Healthcare
Industry: —
Face value: ₹10
Listing date: 23 Nov 2025
Employees: —
Headquarters: Panchkula, India
Website: betadrugslimited.com

07 · About

What is Beta Drugs Limited?

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

08 · Common questions

Frequently asked

What is the CIN of Beta Drugs Limited?+

The Corporate Identity Number for Beta Drugs Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Beta Drugs Limited?+

Promoter and group-holding details for Beta Drugs Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Beta Drugs Limited?+

Beta Drugs Limited (BETA) has a market capitalisation of approximately ₹1906 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent